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Abstract 
Background There is no consensus on the association between exposure to 
hydrocarbons and the risk of Parkinson’s disease (PD). We conducted a systematic 
review and meta-analysis to summarise the epidemiological evidence and included a 
new large case-control study. 
Methods Data were extracted following a predefined protocol. Risk estimates regarding 
the association between hydrocarbon exposure and PD were consolidated to produce a 
summary odds ratio (OR), 95% confidence intervals (CI), and p-value. In our case-
control study, 1463 PD patients and 685 controls were recruited from clinical trials and 
completed a structured questionnaire describing their previous working exposure to 
hydrocarbons and other demographic measures. The association between exposure to 
hydrocarbons and risk of PD was evaluated using logistic regression. 
Results The systematic search identified 13 case-control studies matching the inclusion 
criteria. The meta-analysis included 3020 PD cases and 6494 controls. The summary 
OR was 1.32 (95% CI 1.08-1.62, p=0.006) for hydrocarbon exposure (ever versus 
never). In the PD GEN study, occupational exposure to hydrocarbons significantly 
increased the risk of PD (OR=1.61; 95% CI 1.10-2.36, p=0.014), and risk dose-
dependently increased for subjects exposed greater than 10 years compared to 
subjects never exposed (OR=2.19; 95% CI 1.13-4.26, p=0.021). The addition of PD 
GEN data increased the total numbers to 4483 PD cases and 7179 controls and 
strengthened the significant association (summary OR=1.36; 95% CI 1.13-1.63, 
p=0.001).  
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Conclusions This systematic review supports a positive association between 
hydrocarbon exposure and PD. Data from prospective studies is required to reinforce 
the relationship between hydrocarbon exposure and PD. 
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Introduction 
Parkinson’s disease (PD) is the second most common neurodegenerative condition 
after Alzheimer’s disease, affecting over 100,000 people in the United Kingdom (UK) 
and over one million people in the United States (US) [1]. The prevalence in the 
population is 0.3%, and rises exponentially with age reaching 4% in the highest age 
groups. As the population ages, PD is predicted to cause a major burden on both 
individuals and societies. The aetiology of PD remains largely unknown, although there 
is evidence that both genetic and environmental factors contribute [2]. Despite extensive 
epidemiological studies investigating lifestyle, environmental and occupational risk 
factors, only a small number of factors have shown a consistent association [3;4].  
There is some limited data describing an association between hydrocarbon exposure 
and PD. Hydrocarbons are present in a broad range of products, including petroleum 
and other fuels, solvents, paints, glues and cleaning products [5]. The current 
systematic review and meta-analysis evaluated the relationship between hydrocarbon 
exposure and the risk of PD and included a new case-control study, PD GEN, which 
contained the largest number of PD patients to date. 
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Methods  
Systematic review 
We undertook a systematic search of the published literature to identify observational 
studies that reported exposure to hydrocarbons and PD, in accordance with the 
MOOSE guidelines. The broad search terms listed were combined with an 
observational studies filter as designed by the Scottish Intercollegiate Guidelines 
Network: (Parkinson’s disease OR Parkinson) AND (Hydrocarbon OR Hydrocarbons 
OR Polycyclic Hydrocarbons, aromatic OR Solvent OR Hexane OR Occupational 
Exposure). We searched the Medline and Embase bibliographic databases from 1946 
and 1947 to July 2012, respectively, and screened the reference lists of retrieved 
articles for further relevant papers.  
Studies were included if they met the following eligibility criteria: PD as the outcome of 
interest, an appropriate confirmation of diagnosis (e.g. neurologist or PD inclusion 
criteria or medical records), and present a risk estimate. Chlorinated hydrocarbon 
pesticides were excluded from the review. Double data extraction was performed to 
identify information on the individual studies and participant characteristics. 
Hydrocarbon exposure data was recorded as ever versus never, for use in the meta-
analysis. Additional information was recorded on the length of exposure and specific 
hydrocarbon agents.  
The statistical software RevMan (version 5.1; Cochrane Collaboration 2011) was used 
to analyse the data. The adjusted OR (if adjustment was performed), for each study was 
combined using a generic inverse variance method to produce a summary OR and 95% 
CI [6]. We used a random-effects model and measured the heterogeneity across 
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studies using chi-squared test to calculate the p value and I2 statistic [6]. The I2 statistic 
is a measure of the percentage of total variation across studies that is due to 
heterogeneity beyond chance. To assess potential publication bias we constructed a 
funnel plot and performed an Egger’s test. The analysis was first performed with the 
studies identified in Table 1, and then subsequently including our study, PD GEN, as 
described below. We also stratified by whether non-occupational (i.e studies which 
measured exposure through recreation/hobby) exposure was recorded in the exposed 
group, which allowed us to assess potential differences in intenisty of the hydrocarbon 
exposure. It is important to note, during data extraction two studies presented separate 
occupational and non-occupational risk estimates [7;8]. Thus for these two studies, we 
used these separate odds ratios in the stratified meta-analyses (as these studies did not 
produce an overall risk estimate); and used the occupational only risk estimate in the 
overall meta-analysis as it contained the greatest number of exposed subjects. 
Additional data from our study is described as follows. 
Subjects  
The PD GEN database was created at the Birmingham Clinical Trials Unit and the 
Molecular Neurology Group, School of Clinical and Experimental Medicine, University of 
Birmingham. Recruitment began in June 2002 with patients and carers enrolled in three 
UK wide, large pragmatic randomised control trials (RCTs): PD MED, PD REHAB and 
PD SURG. All patients and carers provided written informed consent and the study was 
approved by the Multicentre Research and Ethics Committee (MREC/00/7/56a). Further 
trial information is available at:  
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http://www.birmingham.ac.uk/research/activity/mds/trials/bctu/trials/index.aspx 
Patients had varying severity and disease duration, thus giving a large representative 
sample of PD patients. All patients enrolled into PD GEN have been diagnosed with PD 
by a neurologist or geriatrician using the UK Parkinson’s Disease Society Brain Bank 
diagnostic criteria for idiopathic PD [9].  By January 2013, a total of 1463 PD patients 
had been recruited to the study. The carer control group consisted of 685 subjects who 
were predominantly spouses but included some friends. Blood relatives were not 
included. Participants were excluded if they were incapable of giving written informed 
consent.  
Data collection 
Data from the PD patients and carer controls were collected using a structured self-
reported questionnaire when they were enrolled in PD GEN, along with a blood sample 
for genetic analyses. The questionnaire requested information on demographic 
characteristics, smoking status, and daily caffeine intake (including coffee and tea 
consumption). Participants were also asked to recall their medical and family history 
(including PD family history up to second degree relatives) and working exposure during 
employment to hydrocarbons.  More detailed questions ascertained the years of 
exposure in employment and an open ended question enquiring about specific 
hydrocarbon agents. To minimise recall and response bias when answering the 
questionnaire, participants were not informed of any potential research hypothesis.  
Data analysis 
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The demographic characteristics were compared between PD cases and controls using 
a Pearson chi-square test for categorical variables and a two-sample t-test for 
continuous variables. Logistic regression models were used to evaluate the association 
between exposure to hydrocarbons and risk of PD. The odds ratios (OR), 95% 
confidence intervals (CIs), p-values and p for trend values for three hierarchical models 
are presented; crude; adjusting for age and sex; and additionally adjusting for cigarette 
smoking, caffeine intake, pesticide exposure and PD family history. Analyses assessed 
exposure to hydrocarbons (ever versus never exposed), with never exposed used as 
the reference group. Separate analyses comparing duration of exposure to 
hydrocarbons were also conducted, comparing 1-9 years of exposure versus never 
exposed and >10 years of exposure versus never exposed. The associations between 
specific hydrocarbon agents (trichloroethylene and carbon tetrachloride), groups of 
hydrocarbon agents (pure hydrocarbons and chlorinated hydrocarbons) and exposure 
to paints were determined in an exploratory manner using the aforementioned logistic 
regression analyses, recognising that such analyses would likely be under powered. All 
tests were 2-sided and p-values of 0.05 or less were considered as statistically 
significant.  Analyses were performed using SPSS statistical software version 20. 
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Results 
Figure 1 shows the process of study selection for the systematic review (PRISMA 
statement). 743 abstracts were screened for relevance, of which 13 eligible studies 
were included in the meta-analysis. The included studies comprised of a total of 3020 
PD patients and 6494 controls.  Supplementary Table 1 shows the information on the 
individual studies and participant characteristics. Figure 2 presents a forest plot 
displaying the association between exposure to hydrocarbons and risk of PD; these 
results indicate that exposure to hydrocarbons is associated with a significantly 
increased risk of PD (OR 1.32; 95% CI 1.08-1.62, p=0.006). There was no significant 
between-study heterogeneity (I2=28%; p=0.17).  
Supplementary Table 2 shows the demographic characteristics of the PD patients and 
their carers from the PD GEN dataset. 1463 PD patients and 685 carer controls were 
recruited. The mean age of PD patients and controls were 75.2±9.4 and 73.1±9.7 years, 
respectively. Of the cases, 66.5% were male compared to only 25.4% males in the 
carer group, thus females were over represented in the carer group compared to the PD 
patient group. Analyses were adjusted for gender in order to adjust for the potential 
confounding effect of this variable. Additionally, sex-stratified analyses were also 
performed. The increased risk estimate in the males was similar to that of the combined 
group, although the effect size was of borderline significance OR=1.59 (CI 0.95-2.65, 
p=0.079). The increased effect size in the females was lower than that observed in the 
male subgroup OR=1.17 (CI 0.62-2.19, p=0.62). Associations between exposure to 
hydrocarbons and risk of PD are presented in Table 1. There was a significantly 
increased risk of PD in individuals who were exposed to hydrocarbons compared to 
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those who were not after adjustment for potential confounding factors  (OR=1.61, 95% 
CI 1.10-2.36, p=0.014). The total years of exposure was also significantly and linearly 
associated with PD (p=0.013), as was exposure for greater than 10 years when 
compared to never exposed subjects (OR=2.19, 95% CI 1.13-4.26, p=0.021). The 
adjusted ORs for the individual hydrocarbon agents and occupational exposure to 
paints suggested an increased risk, but the risk estimates were not statistically 
significant. 
Adding our data slightly modified the effect size of the meta-analysis, and narrowed the 
CIs due to increased sample size (summary OR 1.36; 95% CI 1.13-1.63, p=0.001 
Figure 2). There was no significant heterogeneity between the studies (I2=29%; p=0.15). 
There was limited evidence of publication bias (Supplementary Figure 1; Egger p-
value=0.014), however, when we conducted a sensitivity analysis by removing the two 
anomalous studies with extremely large ORs, there was no significant publication bias 
(Egger p-value=0.14). Figure 3A presents 9 studies which considered occupational 
exposures only, which showed an increased risk (OR 1.49; 95% CI 1.22-1.82, p=0.001). 
Figure 3B presents 7 studies which considered non-occupational exposures in the 
exposed group which increased the summary OR further to 1.57 (95% CI 1.08-2.29, 
p=0.02).  
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Discussion 
The meta-analysis of 13 studies indicated that hydrocarbon exposure was estimated to 
significantly increase the risk of PD by 32%. The observed associations between 
hydrocarbon exposure and PD risk varied from 1.01 to 9.51 across the 13 included 
studies [10;11]. Specifically, the PD GEN data indicate that exposure to hydrocarbons 
was significantly associated with a 61% increased risk of PD, which was consistent with 
the majority of effect sizes incorporated in the meta-analysis.  Adding the PD GEN data 
in the overall meta-analysis of 14 studies slightly increased the overall risk estimate, 
indicating that hydrocarbon exposure increases the risk of PD by 36%. The studies 
included in the meta-analysis had differences in recording and reporting exposures, 
population groups, specific hydrocarbon agents as well as many studies involving few 
cases. Despite this, there was no significant heterogeneity in the overall meta-analysis 
(I2=29%) between the risk estimates of the studies. 
A similar positive association was shown when we stratified by occupational only and 
occupational and/or non-occupational (i.e. recreational/hobby-related) hydrocarbon 
exposures. Occupational only hydrocarbon exposure increased the risk of PD to 49% 
[7;8;11-16]. The risk estimate further increased when occupational and/or non-
occupational exposure studies were also assessed [7;8;17-20], with a calculated 57% 
increased risk albeit with a wider CI. Interestingly, the two studies which presented 
separate risk estimates for occupational and non-occupational exposures also describe 
a larger risk estimate for recreational exposure to hydrocarbons through hobbies [7;8]. 
The increased risk shown in these studies, along with the meta-analysis could be a 
result of either increased mortality prior to the development of PD in occupationally-
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exposed patients; or, a more plausible explanation would be that occupationally/highly-
exposed individuals are provided with legally-required protective equipment that 
prevents inhalation of hydrocarbons and thus attenuates the increased risk of 
developing PD.  
Previous reports of an association between PD and duration/intensity of hydrocarbon 
exposure or specific hydrocarbon agents have been varied. For example, in the largest 
overall case-control study to date, comprising  767 PD patients and 1989 controls, a 
stronger positive association was observed for low exposure when compared to high 
exposure [18]. In contrast the PD GEN study however, demonstrates a significant dose-
trend relationship between increasing hydrocarbon exposure and PD risk. There are 
limited data on specific hydrocarbon agents, the associated risks of which have also 
varied. A recent twin study was the first to identify a significant positive association 
between trichloroethylene exposure and PD, although carbon tetrachloride and pure 
hydrocarbons including toluene, xylene, and N-hexane showed no association [13]. In 
other studies, toluene and naphtha have demonstrated a significant increased risk 
[11;19]. These studies have all used a small sample size with low exposure rates which 
would generate imprecise risk estimates. The PD GEN study measured specific 
exposure to chlorinated hydrocarbons, pure hydrocarbons or paints but no association 
was established, again possibly due to limited power. 
The exact mechanism underlying hydrocarbon’s potential neurotoxicity remains unclear, 
although experimental evidence has shown a range of harmful effects [21]. Using 
magnetic resonance spectroscopy, one study found parkinsonian patients with a high 
solvent exposure history had striatal neuronal damage compared to no damage in low 
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or zero exposed subjects [22]. The results suggested selective vulnerability of the basal 
ganglia to solvent damage which was corroborated by a dose relationship between 
exposure to solvents and neuronal damage [22].  In another study, 36 PD patients with 
history of occupational exposure to hydrocarbons were compared with 38 PD patients 
without exposure and healthy controls. Exposure to hydrocarbons significantly lowered 
striatal dopamine transporter binding measured by 123I-ioflupane SPECT specifically in 
the putamen [23]. A combination of genetic and epidemiological risk factors may be 
required to induce neurodegeneration [24]. There is evidence of genetic polymorphisms 
influencing enzymes which metabolise foreign substances involved in hydrocarbon 
neurotoxicity [21]. Other studies have suggested the metabolism of hydrocarbon can 
produce toxic intermediates which induce mitochondrial dysfunction, through decreased 
complex 1 activity and increased oxidative stress [25]. For instance, trichloroethylene 
has been shown to reduce mitochondrial complex 1 activity in normal rats [26], so it may 
contribute to the risk of PD [27]. Further work is required to determine specific 
mechanisms of hydrocarbon toxicity in PD.  
Systematic review methodology can provide the best overall estimate of the possible 
occupational exposure to hydrocarbons and risk of PD. However, the major limitation of 
the systematic review and meta-analysis was the clarity of the definition of hydrocarbon 
exposure of the included studies. There was a large variety of hydrocarbon agents 
included within the meta-analysis. The heterogeneity of hydrocarbons and products 
containing hydrocarbons may create a problem due to potential differences in 
toxicological properties. It may be that one specific hydrocarbon agent could be driving 
the observed positive association, and thus other agents could be attenuating the risk 
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estimate. As a consequence, we attempted to highlight broad categories of hydrocarbon 
agents to help prospective studies potentially identify a specific group or individual 
hydrocarbon agents that significantly increase the risk of PD. Nevertheless, the meta-
analysis indicates overall hydrocarbon exposure is significantly associated with risk of 
PD [7;8;10-20;28]. Our case-control data are further limited by the use of spouse 
controls which led to differences in the prevalence of the sexes between cases and 
controls [29].  Additionally, the use of spouse controls may have also led to over-
matching for common passive exposures. This would have reduced statistical power 
and underestimated effect size. The differences in prevalence of the sexes adds 
complexity to the interpretation of the data as professions that bring individuals into 
contact with hydrocarbons are more likely to be occupied by males.  Sex stratified 
analyses revealed increased risk of PD with hydrocarbon exposure in both of the 
individual gender subgroups, however the risk estimates of the individual subgroups 
only reached borderline significance in the male subgroup due to the smaller number of 
individuals in the subgroup analyses. Overall the effect sizes observed in the combined 
sample (OR=1.61, 95% CI 1.10-2.36, p=0.014) and the male subgroup (OR=1.59, 95% 
CI 0.95-2.65, p=0.079) were of a similar magnitude, and were in line with those effect 
sizes observed in the review.  
A second limitation is that, our study also included a disproportionate number of white 
participants and is thus not representative of the general UK population.  Thirdly, 
although we adjusted for a number of potential confounders, others were not recorded 
including socioeconomic status, education, diet, and exposure to metals [3].  Lastly, an 
unavoidable limitation of all case-control studies is the lack of a temporal sequence to 
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infer causality and the introduction of recall-bias of the participants’ exposure history. 
The retrospective nature of the questionnaire may have potentially introduced recall 
bias leading to an inaccurate exposure recording and attenuation of effect, which is 
particularly pertinent given the cognitive dysfunction seen in PD. We did not measure 
cognitive impairment upon entry to the study however, patients would not have been 
diagnosed with dementia as this was a criterion for exclusion from the study. In spite of 
these limitations, the results of the current PD GEN study are consistent with those of 
the meta-analysis, supporting the observed association between hydrocarbon exposure 
and PD risk.  
In conclusion, there is growing epidemiological and experimental evidence of an 
association between hydrocarbon exposure and the risk of having PD. Our results 
corroborate previous hydrocarbon studies suggesting that hydrocarbons increase the 
risk of PD by around 36%. Data from large prospective cohort studies are required to 
further evaluate the association between hydrocarbon exposure and PD, expanding on 
these findings from case-control studies.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
 
Acknowledgements 
PD GEN was funded by the Medical Research Council. We thank the individual PD 
patients and carers who agreed to participate in the study and the University of 
Birmingham Clinical Trials Unit for data collection. Thanks are also due to Smitaa Patel, 
Cally Rick, Natalie Ives, and Claire Smith for support and advice during the project; and 
Rita Champaneria for assistance with abstract screening. We also acknowledge a 
personal communication of the results from Professor Walter A. Rocca’s research.  
 
 
 
 
 
 
 
 
 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
References 
 [1]  P. J. Jannetta, D. M. Whiting, L. H. Fletcher, J. Hobbs, J. Brillman, M. Quigley, M. 
Fukui, and R. Williams, "Parkinson's disease: an inquiry into the etiology and 
treatment," Neurology International, vol. 3, pp. 24-27, 2011. 
 [2]  K. Wirdefeldt, H. O. Adami, P. Cole, D. Trichopoulos, and J. Mandel, 
"Epidemiology and etiology of Parkinson's disease: a review of the evidence," 
European Journal of Epidemiology, vol. 26, pp. 1-58, 2011. 
 [3]  L. M. L. De Lau and M. M. B. Breteler, "Epidemiology of Parkinson's disease," 
Lancet Neurology, vol. 5, pp. 525-535, 2006. 
 [4]  A. J. Noyce, J. P. Bestwick, L. Silveira-Moriyama, C. H. Hawkes, G. Giovannoni, 
A. J. Lees, and A. Schrag, "Meta-analysis of early nonmotor features and risk 
factors for Parkinson disease," Annals of Neurology, vol. 72, no. 6, pp. 893-901, 
2012. 
 [5]  C. M. Tanner, G. W. Ross, S. A. Jewell, R. A. Hauser, J. Jankovic, S. A. Factor, 
S. Bressman, A. Deligtisch, C. Marras, K. E. Lyons, G. S. Bhudhikanok, D. F. 
Roucoux, C. Meng, R. D. Abbott, and J. W. Langston, "Occupation and Risk of 
Parkinsonism A Multicenter Case-Control Study," Archives of Neurology, vol. 66, 
pp. 1106-1113, 2009. 
 [6]  G. S. Higgins JPT, "Cochrane Handbook for Systematic Reviews of Inventions 
Version 5.1.0. The Cochrane Collaboration, 2011," 2011. 
 [7]  S. Chaturvedi, T. Ostbye, A. J. Stoessl, H. Merskey, and V. Hachinski, 
"Environmental Exposures in Elderly Canadians with Parkinsons-Disease," 
Canadian Journal of Neurological Sciences, vol. 22, pp. 232-234, 1995. 
 [8]  A. Seidler, W. Hellenbrand, B. P. Robra, P. Vieregge, P. Nischan, J. Joerg, W. H. 
Oertel, G. Ulm, and E. Schneider, "Possible environmental, occupational, and 
other etiologic factors for Parkinson's disease: A case-control study in Germany," 
Neurology, vol. 46, pp. 1275-1284, 1996. 
 [9]  A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, "Accuracy of Clinical-
Diagnosis of Idiopathic Parkinsons-Disease - A Clinicopathological Study of 100 
Cases," Journal of Neurology Neurosurgery and Psychiatry, vol. 55, pp. 181-184, 
1992. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
 [10]  R. Frigerio, K. R. Sanft, B. R. Grossardt, B. J. Peterson, A. Elbaz, J. H. Bower, J. 
E. Ahlskog, M. de Andrade, D. M. Maraganore, and W. A. Rocca, "Chemical 
exposures and Parkinson's disease: a population-based case-control study," 
Movement Disorders, vol. 21, pp. 1688-1692, 2006. 
 [11]  V. D. Hristina, S. B. Sipetic, J. M. Maksimovic, J. M. Marinkovic, E. D. Dzoljic, I. 
S. Ratkov, and V. S. Kostic, "Environmental Factors and Parkinson's Disease: A 
Case-Control Study in Belgrade, Serbia," International Journal of Neuroscience, 
vol. 120, pp. 361-367, 2010. 
 [12]  J. A. Firestone, J. I. Lundin, K. M. Powers, T. Smith-Weller, G. M. Franklin, P. D. 
Swanson, W. T. Longstreth, and H. Checkoway, "Occupational Factors and Risk 
of Parkinson's Disease: A Population-Based Case-Control Study," American 
Journal of Industrial Medicine, vol. 53, pp. 217-223, 2010. 
 [13]  S. M. Goldman, P. J. Quinlan, G. W. Ross, C. Marras, C. Meng, G. S. 
Bhudhikanok, K. Comyns, M. Korell, A. R. Chade, M. Kasten, B. Priestley, K. L. 
Chou, H. H. Fernandez, F. Cambi, J. W. Langston, and C. M. Tanner, "Solvent 
exposures and parkinson disease risk in twins," Annals of Neurology, vol. 71, pp. 
776-784, 2012. 
 [14]  C. G. Ohlson and C. Hogstedt, "Parkinson's disease and occupational exposure 
to organic solvents, agricultural chemicals and mercury. A case-referent study," 
Scandinavian Journal of Work, Environment and Health, vol. 7, pp. 252-256, 
July1981. 
 [15]  M. S. Petersen, J. Halling, S. Bech, L. Wermuth, P. Weihe, F. Nielsen, P. J. 
Jorgensen, E. Budtz-Jorgensen, and P. Grandjean, "Impact of dietary exposure 
to food contaminants on the risk of Parkinson's disease," Neurotoxicology, vol. 
29, pp. 584-590, 2008. 
 [16]  K. Tanaka, Y. Miyake, W. Fukushima, S. Sasaki, C. Kiyohara, Y. Tsuboi, T. 
Yamada, T. Oeda, T. Miki, N. Kawamura, N. Sakae, H. Fukuyama, Y. Hirota, and 
M. Nagai, "Occupational risk factors for Parkinson's disease: a case-control study 
in Japan," Bmc Neurology, vol. 11 2011. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
 [17]  G. De Palma, P. Mozzoni, A. Mutti, S. Calzetti, and A. Negrotti, "Case-control 
study of interactions between genetic and environmental factors in Parkinson's 
disease," Lancet, vol. 352, pp. 1986-1987, 1998. 
 [18]  F. D. Dick, G. De Palma, A. Ahmadi, N. W. Scott, G. J. Prescott, J. Bennett, S. 
Semple, S. Dick, C. Counsell, P. Mozzoni, N. Haites, S. B. Wettinger, A. Mutti, M. 
Otelea, A. Seaton, P. Soederkvist, and A. Felice, "Environmental risk factors for 
Parkinson's disease and parkinsonism: the Geoparkinson study," Occupational 
and Environmental Medicine, vol. 64, pp. 666-672, 2007. 
 [19]  P. Pals, B. Van Everbroeck, B. Grubben, M. K. Viaene, R. Dom, C. van der 
Linden, P. Santens, J. J. Martin, and P. Cras, "Case-control study of 
environmental risk factors for Parkinson's disease in Belgium," European Journal 
of Epidemiology, vol. 18, pp. 1133-1142, 2003. 
 [20]  A. Smargiassi, A. Mutti, A. De Rosa, G. De Palma, A. Negrotti, and S. Calzetti, "A 
case-control study of occupational and environmental risk factors for Parkinson's 
disease in the Emilia-Romagna region of Italy," Neurotoxicology, vol. 19, pp. 709-
712, 1998. 
 [21]  F. D. Dick, "Solvent neurotoxicity," Occupational and Environmental Medicine, 
vol. 63, pp. 221-226, 2006. 
 [22]  M. Rango, M. Canesi, I. Ghione, M. Farabola, A. Righini, N. Bresolin, A. Antonini, 
and G. Pezzoli, "Parkinson's disease, chronic hydrocarbon exposure and striatal 
neuronal damage: A 1-H MRS study," Neurotoxicology, vol. 27, pp. 164-168, 
2006. 
 [23]  M. Canesi, R. Benti, G. Marotta, R. Cilia, I. U. Isaias, P. Gerundini, G. Pezzoli, 
and A. Antonini, "Striatal dopamine transporter binding in patients with 
Parkinson's disease and severe occupational hydrocarbon exposure," European 
Journal of Neurology, vol. 14, pp. 297-299, 2007. 
 [24]  P. M. Carvey, A. Punati, and M. B. Newman, "Progressive dopamine neuron loss 
in Parkinson's disease: The multiple hit hypothesis," Cell Transplantation, vol. 15, 
pp. 239-250, 2006. 
 [25]  A. H. V. Schapira, "Etiology of Parkinson's disease," Neurology, vol. 66, pp. 10-
23, 2006. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
 [26]  M. Liu, D. Y. Choi, R. L. Hunter, J. D. Pandya, W. A. Cass, P. G. Sullivan, H. C. 
Kim, D. M. Gash, and G. Y. Bing, "Trichloroethylene induces dopaminergic 
neurodegeneration in Fisher 344 rats," Journal of Neurochemistry, vol. 112, pp. 
773-783, 2010. 
 [27]  D. M. Gash, K. Rutland, N. L. Hudson, P. G. Sullivan, G. Bing, W. A. Cass, J. D. 
Pandya, M. Liu, D. Y. Choi, R. L. Hunter, G. A. Gerhardt, C. D. Smith, J. T. 
Slevin, and T. S. Prince, "Trichloroethylene: Parkinsonism and complex 1 
mitochondrial neurotoxicity," Annals of Neurology, vol. 63, pp. 184-192, 2008. 
 [28]  G. Pezzoli, M. Canesi, A. Antonini, A. Righini, L. Perbellini, M. Barichella, C. B. 
Mariani, F. Tenconi, S. Tesei, A. Zecchinelli, and K. L. Leenders, "Hydrocarbon 
exposure and Parkinson's disease," Neurology, vol. 55, pp. 667-673, 2000. 
 [29]  B. A. Verhage, K. K. Aben, H. Straatman, A. L. Verbeek, T. H. Beaty, and L. A. 
Kiemeney, "Spouse controls in family case-control studies: a methodological 
consideration," Familial cancer, vol. 2, pp. 101-108, 2003. 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
 
 
 
Table 1- Association between exposure to hydrocarbons, length of exposure and specific exposure and the risk of PD. 
 Cases Controls    
 No.  % No.  % OR (95% CI) 
unadjusted  
OR (95% CI) 
Model 1 
OR (95% CI) Model 
2 
Hydrocarbon exposure 
       
Never 1231 84.5 636 93.1 1 (Ref) 1 (Ref) 1 (Ref) 
Ever 225 15.5 47 6.9 2.59 (1.83-3.68) 
p=0.001 
1.64 (1.12-2.38) 
p=0.01 
1.61 (1.10-2.36) 
P=0.014 
 
Years of Hydrocarbon 
exposure 
       
1-9 62 4.4 18 2.7 1.75 (1.01-3.04) 
p=0.045 
1.32 (0.73-2.38) 
p=0.353 
1.35 (0.75-2.44) 
p=0.323 
>10 108 7.7 12 1.8 4.62 (2.46-8.69) 
p=0.001 
2.28 (1.18-4.40) 
p=0.014 
2.19 (1.13-4.26) 
p=0.021 
p for trend      <0.001 0.010 0.013 
 
 
Hydrocarbon 
       
Chlorinated hydrocarbons 40 3.1 9 1.4 2.31 (1.07-5.01) 
p=0.033 
 
1.54 (0.67-3.49) 
p=0.303 
1.54 (0.68-3.48) 
p=0.303 
Trichloroethylene    13 1.0 3 0.5 3.34 (0.75-14.8) 
p=0.113 
2.39 (0.50-11.3) 
p=0.272 
2.47 (0.52-11.7) 
p=0.255 
Carbon Tetrachloride  21 1.7 2 0.3 4.88 (1.13-21.0) 
p=0.033 
3.46 (0.77-15.6) 
p=0.106 
3.70 (0.81-16.8) 
p=0.09 
        
Pure hydrocarbons 
 
42 3.3 8 1.2 2.79 (1.24-6.29) 
p=0.013 
1.63 (0.69-3.81) 
p=0.263 
1.56 (0.66-3.70) 
p=0.309 
 
Paints 57 4.4 12 1.9 2.52 (1.31-4.86) 
p=0.006 
1.41 (0.71-2.81) 
p=0.33 
1.45 (0.72-2.92) 
p=0.302 
Other 60 4.6 15 2.3 2.44 (1.30-4.59) 
p=0.006 
1.74 (0.89-3.38) 
p=0.104 
1.67 (0.86-3.26) 
p=0.133 
Model 1 adjusted for age and sex. 
Model 2 additionally adjusted for cigarette smoking, caffeine intake, pesticide exposure, and PD family history.  
 
Missing values= Hydrocarbon ever/never n= 9 (0.4%), Hydrocarbon years exposure n=72 (26.5%) - includes the 
participants that have indicated that they have been exposed but not stated how long for. Specific hydrocarbon agents n=50 
missing (18.7%).  
Note some participants had been exposed to more than 1 type of Hydrocarbon. 
Chlorinated hydrocarbons contain participants exposed to trichloroethylene, carbon tetrachloride, and other chlorinated 
hydrocarbons (n=10) including perchloroethylene, chloroform and chlorobenzene. 
Pure hydrocarbons contain participants exposed to benzene, toulene, xylene, hexane, and petroleum/petroleum derivatives 
including fuel oil, natural gas, kerosene 
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Figure 1- PRISMA flow diagram, process of study selection. 
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Figure 2 Summary odds ratio from 13 case-control studies, and the PD GEN study of 
hydrocarbon exposure and Parkinson’s disease (ever versus never). 
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Figure 3 Summary odds ratios from case-control studies of occupational 
hydrocarbon exposure (A) and non-occupational hydrocarbon exposure (B) and 
Parkinson’s disease (ever versus never). 
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We did a systematic review of hydrocarbon exposure and the risk of Parkinson’s 
disease. 
We included a new large case-control study of hydrocarbons and Parkinson’s 
disease. 
There was a significant association between hydrocarbons and the risk of 
Parkinson’s disease. 
Data from prospective studies is required to reinforce this relationship with 
hydrocarbons. 
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Supplementary Table 1 Overview of the studies included in the meta-analyses 
Study Location 
 
Methods of 
recording 
exposure 
location of 
recruitment 
Exposure Exposure 
ascertainment 
(Ever/Never) 
 
 
No. 
exposed 
cases/ 
Total 
number of 
cases 
No. 
exposed 
controls/ 
Total 
number of 
controls 
Odds 
Ratio (95% 
Cl) 
Adjustment 
factors 
 
Other information 
Goldman et 
al (2012) 
U.S Interview Research Council 
WWII veteran 
twins registry 
n-hexane, 
Xylene, 
Toulene, CCl4, 
TCE and PERC 
Occupational 
exposure.  
 
2% of work time 
or 1 hour per 
week. 
19/99 14/99 1.7 
(0.8-3.7) 
p=0.16 
Age, head 
injury, and 
zygosity. 
Twin study, all male 
cohort. 
Tanaka et al 
(2011) 
Japan Self-reporting 
questionnaire 
Hospital Solvents Occupational 
exposure.  
 
10hrs per week of 
more than 1 year. 
7/249 12/369 1.10 
(0.38-2.95) 
p=0.91 
 
Age, 
education, 
smoking, 
place of 
residence. 
- 
Hristina et al 
(2010) 
Serbia Interview University clinical 
centre 
Naphtha and 
its derivates 
Occupational 
exposure. 
 
 
13/110 1/220 9.53  
(1.04-87.0)  
p=0.046 
Age, sex and 
smoking 
Controls were 
degenerative joint 
disease or GIT disease 
patients. 
Firestone et 
al (2010) 
U.S Interview Population-based Solvents Occupational 
exposure 
156/404 140/526 1.23  
(0.69-2.18) 
p=0.49 
Age, sex, 
smoking, and 
ethnicity. 
OR were presented a 
separately for gender. 
We calculated joint OR. 
Peterson et 
al (2008) 
Faroe 
Islands 
Interview Population-based Solvents Occupational 
exposure  
19/79 32/154 1.68  
(0.80-3.50) 
p=0.17 
Age, sex and 
smoking 
- 
Dick et al 
(2007) 
Scotland, 
Sweden, 
Italy, 
Romania 
and Malta 
Interview Mixture of clinics, 
hospitals and 
community.  
Solvents  Occupational and 
hobby exposure.  
 
 
Average Annual 
Intensity (AAI) 
 
?/767 ?/1989 1.06  
(0.86-1.30) 
p=0.60 
Age, sex, 
smoking, PD 
family 
history, 
knocked 
unconscious, 
and country. 
Five centre case-
control study.  
 
Larger association with 
low exposure when 
compared to high 
exposure. 
Frigerio et al 
(2006) 
U.S  Interview- 
telephone 
Population-based Paints, 
varnishes, 
cleaning 
products, 
petroleum 
derivatives, 
glues/printing 
products.  
Occupational and 
hobby exposure 
39/149 33/129 1.0  
(0.60-1.70) 
p=0.97 
Age and sex Presented separate OR 
for gender.  
 
Personal 
communication with 
authors obtained 
overall OR.  
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Pals et al 
(2003) 
Belgium 
(Flanders) 
Self-reporting 
questionnaire 
PD support 
groups and 
spouse controls 
Toluene  Over 6 months 
exposure prior to 
onset of PD.  
23/423 1/205 7.8  
(1.03-58.8) 
p=0.047 
Age, sex and 
PD family 
history. 
- 
De Palma et 
al (1998) 
Italy Self-reporting 
questionnaire 
Hospital Solvents Occupational or 
residential contact 
for at least 10 
consecutive years 
before PD onset. 
24/100 43/200 1.15  
(0.65-2.03) 
p=0.63 
- - 
Smargiassi et 
al (1998) 
Italy Interview Hospital Organic 
solvent 
Substantial leisure 
and jobs. At least 
10 consecutive 
years 
23/86 12/86 2.78  
(1.23-6.26)  
p=0.014 
- - 
Seidler et al 
(1996) 
Germany Interview Clinics, and 
random 
neighbourhood 
and regional 
controls 
Solvents Occupational 
exposure. 
 
And separate 
recreational 
exposure (hobby) 
100/376 79/372 1.60  
(1.10-2.40) 
p=0.015  
Education 
and smoking. 
Presented a range of 
products hydrocarbon 
products.  
 
Larger association with 
hobby exposure. 
Chaturvedi 
et al (1995) 
Canada Self-reporting 
questionnaire 
Population-based Gasoline, 
fuels and oils 
Occupational 
exposure 
 
And separate 
recreational 
exposure (hobby) 
23/87 489/2070 1.15  
(0.60-2.11) 
p=0.71 
- Presented a range of 
products hydrocarbon 
products.  
 
Larger association with 
hobby exposure. 
Ohlson C-G 
and Hogstedt 
(1981) 
Sweden Self-reporting 
questionnaires 
2 Hospitals Solvents  Occupational 
exposure.  
 
6 months work 
with solvents 
16/91 12/75 1.1  
(0.40-2.90) 
p=0.88 
- Controls were 
subarachroid 
hemorrhage patients. 
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Supplementary Table 2- The demographic characteristics of the PD GEN PD cases and carer-
controls 
 
Characteristic 
Cases Control 
No. % No.  % 
Participants 1463 68.1 685 31.9 
Gender 
    
   Male 973 66.5 174 25.4 
   Female 490 33.5 511 74.6 
Age, mean (SD) 75.2 (9.38)  73.1 (9.71) 
Cigarette smoking 
    
   Never smokers 667 47.1 345 52.8 
   Ever smokers 750 52.9 309 47.2 
Pesticide exposure 
    
   Never exposed 1327 91.1 644 94.4 
   Ever exposed 130 8.9 38 5.6 
Caffeine intake, mean 
(SD) 
4.8 (2.0)  5.0 (1.9)  
Place of resident 
    
   Town/city 577 39.5 255 37.5 
   Countryside  345 23.6 169 24.9 
   Mixture of both 540 36.9 256 37.6 
Ethnicity 
    
   White 1422 97.5 676 98.8 
   Black  6 0.4 1 0.1 
   Asian 30 2.1 7 1.0 
Parkinson’s family 
history 
    
   No 1302 90.0 640 94.1 
   Yes 145 10.0 40 5.9 
Values calculated by Chi-squared and independent t-test 
Missing values: 
Smoking- n=77 (3.6%) 
Caffeine intake- n=5 (0.2%) 
Pesticide exposure- n=9 (0.4%) 
Place of Residence- n=6 (0.3%) 
Ethnicity- n=5 (0.2%)  
PD family history- n=21 (1%) 
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Supplementary Figure 1: Funnel plot with 13 included studies 
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